Patents Assigned to GUDUI BIOPHARMA TECHNOLOGY INC.
  • Publication number: 20160256481
    Abstract: Disclosed in the present invention is the use of a water soluble platinum complex in preparing drugs for the prevention and treatment of tumors, said platinum complex being shown as formula (I). Experiments have demonstrated that the present water soluble platinum complex alone or in combination with other chemotherapeutics is able to treat cancer in mammals, and in particular, humans, said cancers including lung cancer, colon cancer, head and neck cancer, prostate cancer, breast cancer, ovarian cancer, cervical cancer, leukemia, lymphoid cancer, skin cancer, pancreatic cancer, liver cancer, bladder cancer, esophageal cancer, gastric cancer, male genital cancer or bone cancer.
    Type: Application
    Filed: June 22, 2012
    Publication date: September 8, 2016
    Applicant: GUDUI BIOPHARMA TECHNOLOGY INC.
    Inventors: Yiqiang WANG, Yang LIU
  • Publication number: 20150051387
    Abstract: Disclosed are water-soluble platinum complexes for tumor treatment and preparation method, said platinum complexes being shown as formula (I); The present platinum complexes exhibiting superior cytotoxicity and efficacy compare to the clinical drug oxaliplatin, the design strategy of the present platinum complexes is to enhance the solubility and stability favor its clinical use.
    Type: Application
    Filed: June 22, 2012
    Publication date: February 19, 2015
    Applicant: GUDUI BIOPHARMA TECHNOLOGY INC.
    Inventors: Yiqiang Wang, Yang Liu
  • Publication number: 20150011740
    Abstract: Disclosed are fluorine-containing highly water-soluble platinum complexes for tumor treatment and preparation method, said platinum complexes being shown as formula (I); The present fluorine-containing platinum complexes exhibiting superior cytotoxicity and efficacy compare to the clinical drug oxaliplatin, the design strategy of the present platinum complexes is to enhance the solubility and stability favor its clinical use.
    Type: Application
    Filed: June 22, 2012
    Publication date: January 8, 2015
    Applicants: GUDUI BIOPHARMA TECHNOLOGY INC., JUANG SU VANGUARD PHARMACY CO.LTD,
    Inventors: Yiqiang Wang, Yang Liu